European Cancer Organisation shared on LinkedIn:
“Early detection saves lives. And the difference can be dramatic.
- Breast cancer: over 90% five-year survival at Stage I vs 20–30% at Stage IV
- Lung cancer: over 60% when localised vs less than 10% when spread
- Prostate cancer: over 95% when localised vs around 30% when metastatic
This EU Screening Week we say it loud and proud: screening should not be a luxury – but a right.
WHO’s European Observatory on Health Systems and Policies recommends EU countries modernise population – based cancer screening by:
- Deploying key innovations such as self – sampling, risk – stratified screening and AI-assisted image reading
- Moving towards organised and more risk – based screening
- Investing in health – professional training, strong data infrastructure, public communication and robust evaluation
Learn more from our member, the European Radiology Society
And read the full WHO policy brief.”
Other articles about European Cancer Organisation on OncoDaily.